Extended-Release Medication

Why Choose an Extended-Release Medication Treatment?

Less Daily Pressure

Built for Real Life

Increased Privacy

Improved Safety

The Science of the “Steady State”

Extended-Release Treatment Options

Sublocade is a once-monthly extended-release buprenorphine medication for patients who want long-term stability without daily dosing. 

Using a solidifying gel delivery system, Sublocade forms a depot under the skin that releases medication steadily over 30 days. 

Brixadi offers flexible extended-release buprenorphine treatment with both weekly and monthly dosing options. 

That flexibility can allow patients to start with more frequent support and move to longer intervals as stability improves. 

With a smaller injection volume and multiple approved injection sites, Brixadi can be adapted to a wide range of treatment needs. 

Vivitrol is a once-monthly, non-opioid extended-release medication that works by blocking receptors rather than activating them. 

It is FDA-approved for both opioid use disorder and alcohol use disorder, making it a distinct option for patients who want a non-narcotic treatment path. 

Is an Extended-Release Medication Option Right for You?

A Simpler Way to Stay Consistent, With Middlesex Recovery

Recovery already requires energy and focus. Your treatment plan should help reduce stress, not add more of it. 

Extended-release MAT can remove daily decision-making, lower treatment burden, and provide steady support in the background so you can keep moving forward. 

If you are ready to explore treatment beyond daily dosing, Middlesex Recovery can help you learn whether an extended-release medication is the right fit. 

Talk with our medical team to find the extended-release option that aligns with your recovery goals. We can help you build a treatment plan that includes medication, counseling, and ongoing support.